###begin article-title 0
###xml 91 131 91 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Telomerase Reverse Transcriptase (hTERT)</italic>
Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene
###end article-title 0
###begin p 1
Conceived and designed the experiments: DX QZ CL. Performed the experiments: QZ CL ZG XF XZ KS. Analyzed the data: DX QZ CL ZG XF MB. Contributed reagents/materials/analysis tools: KS. Wrote the paper: DX MB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 199 239 199 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">telomerase reverse transcriptase (hTERT)</italic>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
Lysine-specific demethylase 1 (LSD1), catalysing demethylation of mono- and di-methylated histone H3-K4 or K9, exhibits diverse transcriptional activities by mediating chromatin reconfiguration. The telomerase reverse transcriptase (hTERT) gene, encoding an essential component for telomerase activity that is involved in cellular immortalization and transformation, is silent in most normal human cells while activated in up to 90% of human cancers. It remains to be defined how exactly the transcriptional activation of the hTERT gene occurs during the oncogenic process.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
In the present study, we determined the effect of LSD1 on hTERT transcription. In normal human fibroblasts with a tight hTERT repression, a pharmacological inhibition of LSD1 led to a weak hTERT expression, and a robust induction of hTERT mRNA was observed when LSD1 and histone deacetylases (HDACs) were both inhibited. Small interference RNA-mediated depletion of both LSD1 and CoREST, a co-repressor in HDAC-containing complexes, synergistically activated hTERT transcription. In cancer cells, inhibition of LSD1 activity or knocking-down of its expression led to significant increases in levels of hTERT mRNA and telomerase activity. Chromatin immunoprecipitation assay showed that LSD1 occupied the hTERT proximal promoter, and its depletion resulted in elevated di-methylation of histone H3-K4 accompanied by increased H3 acetylation locally in cancer cells. Moreover, during the differentiation of leukemic HL60 cells, the decreased hTERT expression was accompanied by the LSD1 recruitment to the hTERT promoter.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 431 436 <span type="species:ncbi:9606">human</span>
LSD1 represses hTERT transcription via demethylating H3-K4 in normal and cancerous cells, and together with HDACs, participates in the establishment of a stable repression state of the hTERT gene in normal or differentiated malignant cells. The findings contribute to better understandings of hTERT/telomerase regulation, which may be implicated in the development of therapeutic strategies for telomerase dysregulation-associated human diseases including cancers.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Berger1">[1]</xref>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ruthenburg1">[2]</xref>
###xml 519 522 519 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi1">[3]</xref>
###xml 860 863 860 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Berger1">[1]</xref>
###xml 864 867 864 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi1">[3]</xref>
The post-translational modification of nucleosomal histones, including acetylation, phosphorylation, methylation, ubiquitination and sumoylation, plays a key role in the regulation of gene transcription through remodelling chromatin structure [1]. Among all above modifications, regulated methylation of six known lysine (K) residues within the tails of histone H3 (H3-K4, H3-K9, H3-K27, H3-K36 and H3-K79) and H4 (H4-K20) is unique as mono- (M1), di- (M2) and tri- (M3) three modification states can be generated [2], [3]. These different states, together with the identity of the modified lysine residues, result in diverse consequences on transcriptional activities. Methylation of H3-K4, H3-K36 and H3-79 is predominantly associated with transcriptionally active genes, whereas methylation of H3-K9, H3-K27 and H4-K20 marks silent genes or heterochromatin [1]-[3].
###end p 9
###begin p 10
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Berger1">[1]</xref>
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi1">[3]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ruthenburg1">[2]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Christensen1">[5]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi2">[6]</xref>
###xml 592 595 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Metzger1">[7]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Rudolph1">[15]</xref>
###xml 949 952 949 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Metzger1">[7]</xref>
###xml 954 958 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Kahl1">[11]</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wang1">[13]</xref>
###xml 1139 1142 1139 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi2">[6]</xref>
###xml 1144 1147 1144 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee1">[8]</xref>
###xml 1149 1153 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wang1">[13]</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi3">[16]</xref>
###xml 1161 1165 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee2">[17]</xref>
It is well known that histone acetylation and phosphorylation are dynamic and reversible, while histone methylation has long been thought as a static modification [1]-[3]. However, the recent discovery of multiple histone demethylases (HDMs) has totally changed this dogma, and thus the dynamic histone H3 methylation-mediated transcriptional regulation has emerged as a subject of intense investigations [2]-[5]. Lysine-specific demethylase 1 (LSD1), the first identified HDM [6], has attracted a great deal of interest because of its broad functional activities in transcriptional programs [7]-[15]. By interacting with diverse co-factors and catalyzing demethylation of mono- and di-methylated H3-K4 or K9, LSD1 is capable of either repressing or activating the target genes. For instance, when recruited to the target promoters by the androgen receptor, LSD1 removed the repressive H3-K9(M2) mark, thereby driving the androgen target activation [7], [11]-[13]. On the other hand, LSD1 specifically demethylates H3-K4(M1) and (M2) that in turn leads to gene repression by maintaining a unmethylated H3-K4 status on its target promoters [6], [8], [13], [16], [17]. By eliciting such dual effects, LSD1 has been implicated in embryonic development, cell differentiation and proliferation, stem and cancer cell biology.
###end p 10
###begin p 11
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Blasco1">[18]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shay1">[19]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Blasco1">[18]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shay1">[19]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Sarin1">[20]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Flores1">[21]</xref>
###xml 543 583 543 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">telomerase reverse transcriptase (hTERT)</italic>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Cong1">[22]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lin1">[26]</xref>
###xml 904 909 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Telomerase, a RNA-dependent DNA polymerase silent in most normal human somatic cells, is frequently activated during the oncogenic process [18], [19]. The compelling evidence suggests that activation of telomerase is essential for cellular immortalization and malignant transformation [18], [19]. Moreover, telomerase and/or its components have also been implicated in the regulation of stem cell mobilization and proliferation [20], [21]. It has been established that the stable repression of the telomerase catalytic subunit, encoded by the telomerase reverse transcriptase (hTERT) gene, is a predominant event resulting in the lack of telomerase activity in most normal cells [22]-[26]. Therefore, in order to acquire telomerase activity, it is necessary to erase negative regulators suppressing hTERT transcription. However, it remains incompletely understood how the repression or activation of the hTERT gene in normal and cancerous cells is achieved, despite great efforts in elucidating the underlying mechanisms during the past years.
###end p 11
###begin p 12
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Hou1">[27]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Atkinson1">[35]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Liu2">[34]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Atkinson1">[35]</xref>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Horikawa2">[36]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Takakura2">[37]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Guccione1">[38]</xref>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Recent studies have started to uncover a close association between histone modifications including methylation and transcriptional activity of the hTERT gene in human cells [27]-[35]. Lack of histone H3-K4 methylation generally marks the repressive hTERT transcription in telomerase-deficient cells while the over-expression of SMYD3, a histone methyltransferase (HMT) that specifically di- and tri-methylates histone H3-K4, leads to the induction of hTERT mRNA expression via enhancing methylated H3-K4 at the hTERT proximal promoter region [34], [35]. It has been shown that the transcription factor c-MYC, a key activator of the hTERT gene [36], [37], is capable of binding to its target promoters only when the H3-K4 is methylated within appropriate regions of target promoters [38]. Conceivably, histone H3-K4 demethylation at the hTERT promoter may be required to lock the chromatin in a closed state in telomerase-deficient cells. However, it remains unknown which HDMs are associated with the hTERT promoter and responsible for maintaining H3-K4 demethylation locally. In the present study, we sought to address this issue by determining the potential role for LSD1 in controlling hTERT transcription.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Tranylcypromine treatment or depletion of LSD1 expression induces hTERT mRNA expression in MRC5 fibroblasts
###end title 14
###begin p 15
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee2">[17]</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1A</xref>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1B</xref>
###xml 251 256 <span type="species:ncbi:9606">human</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
The amino oxidase inhibitor tranylcypromine has been identified to potently suppress the enzymatic activity of LSD1 [17]. Therefore, to elucidate a potential role for LSD1 in the transcriptional regulation of the hTERT gene, we first incubated normal human MRC5 fibroblasts exhibiting a stable hTERT repression in the presence of tranylcypromine. As shown in Fig. 1A, hTERT transcripts were not observed in control MRC5 cells while tranylcypromine treatment induced a weak but detectable expression of hTERT mRNA. To rule out possible LSD1-independent, non-specific effects of tranylcypromine, we knocked-down LSD1 expression by using the specific LSD1 siRNA. siRNA treatment of MRC5 cells resulted in silencing of LSD1 expression, and consistent with the finding described above, hTERT mRNA was induced in these LSD1-depleted cells (Fig. 1B). Taken together, both pharmacological inhibition of LSD1 activity and depletion of its expression are capable of de-repressing the hTERT transcription in normal human fibroblasts, although the effect was not robust.
###end p 15
###begin title 16
###xml 84 89 <span type="species:ncbi:9606">human</span>
The effect of LSD1 inhibition on the hTERT mRNA expression or gene transcription in human normal fibroblast MRC5 cells.
###end title 16
###begin p 17
###xml 1340 1347 1329 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
(A) The induction and synergistic up-regulation of hTERT mRNA expression in MRC5 cells by the LSD1 inhibitor tranylcypromine alone and its combined treatment with the histone deacetylase (HDAC) inhibitor TSA, respectively. The cells were incubated with either tranylcypromine at 25.0 microM or TSA 0.1 microM, or both of them overnight and then harvested for hTERT mRNA analyses using RT-PCR. Trans: tranylcypromine. (B) The synergistic effect of LSD1 and CoREST depletion on the induction of hTERT mRNA in MRC5 cells. The knocking-down of LSD1 and CoREST expression was performed using the specific siRNA targeting LSD1 and CoREST. Arrow: primer dimmers. (C) The demonstration of efficient down-regulation of the target genes in siRNA-transfected cells. Lane 1: Control siRNA; lane 2: LSD1 (Upper) and CoREST siRNAs (Lower), respectively; and lane 3: LSD1+CoREST siRNAs. Note the results in (B) and (C) were from the same set of cDNA, and therefore, beta2 -M was only shown in (B). (D) The up-regulation of the hTERT promoter activity by tranylcypromine. The p181 reporter construct that harbors the hTERT proximal promoter sequence was transfected into MRC5 cells in the absence or presence of tranylcypromine, and then analysed for luciferase activity 48 hours later. Variation in transfection efficiency was normalized by the TK-driven Renilla luciferase activity. Columns: Relative luciferase activity arbitrarily expressed as the ratio of p181/TK; Bars: SD.
###end p 17
###begin title 18
The simultaneous inhibition of both LSD1 and HDACs is required for the optimal induction of hTERT mRNA expression in MRC5 cells
###end title 18
###begin p 19
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Hou1">[27]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Cong2">[28]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Takakura1">[31]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ge1">[33]</xref>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Xu1">[39]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee3">[40]</xref>
###xml 726 733 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1A</xref>
###xml 821 826 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 851 856 <span type="species:ncbi:9606">human</span>
It has been previously shown that the inhibition of HDAC activity by TSA activates hTERT transcription in human fibroblasts and other cell types [27], [28], [31]-[33], [39]. Moreover, an intimate interplay between LSD1 and HDACs has been observed [40]. We thus sought to probe whether a synergistic induction of hTERT expression could be achieved by inhibiting both LSD1 and HDAC activities. For this purpose, MRC5 cells were exposed to either tranylcypromine or TSA alone, or tranylcypromine plus TSA. A weak expression of hTERT mRNA was observed in cells treated with tranylcypromine at 25 microM or TSA at 0.1 microM, whereas the cell exposure to both tranylcypromine and TSA led to a robust increase in hTERT transcripts (Fig. 1A). The data suggest that LSD1 and HDACs cooperate to maintain a repressive state of the hTERT transcription in normal human MRC5 cells.
###end p 19
###begin p 20
###xml 103 106 103 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee1">[8]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi3">[16]</xref>
###xml 346 353 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1C</xref>
###xml 541 548 541 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1B</xref>
It is known that LSD1 interacts with CoREST, a co-repressor that exists in the HDAC-containing complex [8], [16]. To corroborate the specific effect of tranylcypromine and TSA, we thus depleted both LSD1 and CoREST expression in MRC5 cells using a siRNA approach. The efficient knocking-down of these transcripts was verified with use of RT-PCR (Fig. 1C). The transfection of LSD1 but not CoREST siRNA into MRC5 cells induced minimal amounts of hTERT mRNA whereas the depletion of both of them synergistically activated hTERT transcription (Fig. 1B), which was in good accordance with the results achieved in MRC5 cells incubated with both tranylcypromine and TSA.
###end p 20
###begin title 21
The hTERT promoter is activated in MRC5 cells in the presence of tranylcypromine
###end title 21
###begin p 22
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Takakura2">[37]</xref>
###xml 682 689 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g001">Fig. 1D</xref>
Next we sought to examine the effect of tranylcypromine on the hTERT promoter activity. p181, a reporter construct with an insert of the core hTERT promoter sequence [37], was transfected into MRC5 cells and luciferase activity driven by the hTERT core promoter was assessed 48 hours post-transfection in the presence or absence of tranylcypromine. As expected, the p181 activity in untreated MRC5 cells was very low, consistent with earlier observations. The exposure of the cells to tranylcypromine substantially increased the hTERT promoter activity in a dose-dependent manner (Control vs tranylcypromine treatment at 10 and 100 microM, p<0.05, paired Wilcoxon two sample test) (Fig. 1D).
###end p 22
###begin title 23
Tranylcypromine up-regulates hTERT expression and telomerase activity concomitant with elevated H3-K4(M2) and H3 acetylation at the hTERT proximal promoter in cancer cells
###end title 23
###begin p 24
###xml 458 465 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2A</xref>
###xml 878 885 874 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2B</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Having demonstrated an inhibitory role for LSD1 in the hTERT transcription in human normal fibroblasts, we wanted to further clarify its regulatory effect on hTERT expression in different cancer cells. The cervical cancer lines HeLa, SiHa and SW756, and a lung cancer line A549 cells were incubated with different concentrations of tranylcypromine overnight and were then analyzed for changes in hTERT mRNA and telomerase activity. The results documented in Fig. 2A showed a significant up-regulation of hTERT mRNA expression in all tranylcypromine-treated cells although the sensitivity varied from cell line to cell line. HeLa cells were most sensitive to tranylcypromine treatment and the concentration at 10 microM induced optimal increases in hTERT mRNA. Consistently, an increase in telomerase activity was observed in the same sets of A549, SiHa and SW756 cells as well (Fig. 2B). HeLa cells treated with 100 microM tranylcypromine exhibited slight enhancement in telomerase activity, in accordance with hTERT mRNA results.
###end p 24
###begin title 25
###xml 188 193 <span type="species:ncbi:9606">human</span>
The tranylcypromine-induced up-regulation of hTERT mRNA expression and telomerase activity accompanied by increase in H3-K4(M2) and H3 acetylation at the hTERT proximal promoter region in human cancer cells.
###end title 25
###begin p 26
(A) The dose-dependent up-regulation of hTERT mRNA expression in A549, HeLa, SiHa and SW756 cells treated with tranylcypromine. (B) Telomerase activity in the same sets of cells treated with tranylcypromine (Trans) at 100 microM (for A549, HeLa and SW756) or 50 microM (for SiHa) as in (A). Telomerase activity was assessed using a telomerase PCR ELISA kit and arbitrarily expressed as absorbance (OD450-OD690). Columns: Relative telomerase activity; Bars: SD. (C) The western blot analysis of global histone H3 acetylation, H3-K4, and H3-K9 mono-, di- and tri-methylation in HeLa and SiHa cells treated with tranylcypromine (Trans). Pansus staining was shown for equal histone protein loads. (D) The increased histone H3-K4(M2) and H3 acetylation at the hTERT proximal promoter in tranylcypromine-treated HeLa and SiHa cells. Representative ChIP results were shown.
###end p 26
###begin p 27
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee2">[17]</xref>
###xml 393 400 393 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2C</xref>
###xml 767 774 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2D</xref>
###xml 1077 1084 1077 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2D</xref>
###xml 1182 1189 1182 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g002">Fig. 2D</xref>
Given tranylcypromine's inhibitory effect on LSD1 activity [17], we next asked whether potential alterations in histone H3 methylation occurred in cells treated with tranylcypromine. We first recorded a change in global histone H3 methylation and acetylation profile in control and treated cells, but failed to find a significant difference in total methylated H3-K4 and K9 or H3 acetylation (Fig. 2C). Chromatin immunoprecipitation (ChIP) assays were then applied to determine histone H3 modifications at the hTERT promoter region by using the PCR primers spanning the proximal promoter regions (between -296 and -22 relative to ATG). The treatment of HeLa cells with the LSD1 inhibitor led to substantial enrichments in H3-K4(M2) at the hTERT core promoter region (Fig. 2D). Similar alterations were observed in SiHa cells following tranylcypromine treatment: H3-K4(M2) at the hTERT promoter was increasingly enriched. Furthermore, highly increased histone H3 acetylation at the hTERT promoter region was found in both HeLa and SiHa cells in the presence of tranylcypromine (Fig. 2D). In contrast, no significant H3-K9 methylation(M2) was detected at the hTERT proximal promoter (Fig. 2D). These data indicate that LSD1 specifically demethylates H3-K4 rather than K9 associated with the hTERT proximal promoter, consistent with its inhibitory effect on the hTERT transcription. Additionally, we found that the altered H3-K4 modification was limited to the core promoter region and did not extend to the promoter nucleosomes further upstream (>-700 and beyond; data not shown).
###end p 27
###begin title 28
Depleting LSD1 expression induces higher levels of hTERT mRNA and telomerase activity via inhibiting H3-K4 demethylation at the hTERT proximal promoter in cervical cancer cells
###end title 28
###begin p 29
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3A</xref>
###xml 438 451 438 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3A and B</xref>
To obtain independent evidence for the inhibitory effect of LSD1 on hTERT transcription and telomerase activity, LSD1 expression was further knocked-down in HeLa and SiHa cells again using a siRNA strategy. As shown in Fig. 3A, LSD1 could be efficiently depleted in HeLa and SiHa cells. The up-regulation of hTERT mRNA and telomerase activity was observed in both cells, consistent with those documented in tranylcypromine-treated cells (Fig. 3A and B).
###end p 29
###begin title 30
LSD1-depletion mediated up-regulation of hTERT and telomerase expression through enhancing H3-K4(M2) and H3 acetylation at the hTERT proximal promoter in cancer cells.
###end title 30
###begin p 31
###xml 79 84 <span type="species:ncbi:9606">human</span>
(A) The up-regulation of hTERT mRNA expression induced by depletion of LSD1 in human cancer cells. RT-PCR for LSD1 mRNA was shown to verify efficient depletion of LSD1 expression in those cells. The lower panel further demonstrated an inhibition of LSD1 expression at protein levels in HeLa and SiHa cells treated with LSD1 siRNA. WB: Western blot. (B) The enhanced telomerase activity in HeLa and SiHa cells with LSD1 depletion. (C) The western blot analysis of global histone H3 acetylation, H3-K4, and H3-K9 mono-, di- and tri-methylation in HeLa and SiHa cells transfected with LSD1 specific siRNA. Pansus staining was shown for equal histone protein loads. (D) The abolishment of LSD1 concomitant with the increased H3-K4(M2) and H3 acetylation at the hTERT proximal promoter in LSD1-depleted HeLa and SiHa cells. Representative ChIP results were shown. C and L: Control and LSD1 siRNA, respectively.
###end p 31
###begin p 32
###xml 131 138 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3C</xref>
###xml 446 453 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3D</xref>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3D</xref>
###xml 745 752 745 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g003">Fig. 3D</xref>
###xml 808 813 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
The depletion of LSD1 in HeLa and SiHa cells did not lead to global changes in the histone H3 methylation and acetylation profile (Fig. 3C). We then performed ChIP analyses to define potential alterations in H3 methylation associated with the hTERT proximal promoter in LSD1-depleted cells. The presence of LSD1 on the hTERT promoter was readily observed in the control cells while it became undetectable following LSD1-specific siRNA treatment (Fig. 3D). The depletion of LSD1 expression was accompanied by significant increases in H3-K4(M2) and histone H3 acetylation at the hTERT promoter in both HeLa and SiHa cells (Fig. 3D). There were no detectable histone H3-K9(M2) at the hTERT promoter region in either control or LSD1-depleted cells (Fig. 3D). These results provide evidence that LSD1 targets the hTERT gene and represses hTERT transcription via specifically demethylating histone H3-K4 (M2) at the hTERT proximal promoter in cervical cancer cell lines.
###end p 32
###begin title 33
The recruitment of LSD1 to the hTERT promoter accompanied by a loss of H3-K4(M2) and down-regulation of hTERT expression occur concomitantly during the terminal differentiation of leukemic HL60 cells
###end title 33
###begin p 34
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Xu1">[39]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Albanell1">[41]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Holt1">[45]</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 546 553 546 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g004">Fig. 4A</xref>
###xml 821 828 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001446-g004">Fig. 4B</xref>
It has been well clarified that HL60 leukemic cells, when induced to undergo terminal differentiation, exhibit a stable repression of hTERT transcription [39], [41]-[45]. To explore whether LSD1 is involved in the establishment of such a repressive state of the hTERT gene in the differentiated HL60 cells, we treated the cells with DMSO, a differentiation inducer, and then analysed binding of LSD1 to the hTERT proximal promoter. As expected, the DMSO exposure of HL60 cells triggered complete cessation of hTERT transcription within 48 hours (Fig. 4A). The ChIP results showed that LSD1 recruitment to the hTERT promoter did not occur in undifferentiated cells while it was readily observed in differentiated cells treated with DMSO for 48 hours, concomitant with the loss of H3-K4(M2) at the hTERT proximal promoter (Fig. 4B).
###end p 34
###begin title 35
The recruitment of LSD1 to the hTERT proximal promoter concomitant with repression of hTERT transcription in the differentiated HL60 cells.
###end title 35
###begin p 36
(A) The down-regulation of hTERT mRNA expression in HL60 cells undergoing terminal differentiation induced by DMSO treatment. (B) The presence of LSD1 concomitant with a loss of H3-K4(M2) at the hTERT proximal promoter region in differentiated but not undifferentiated HL60 cells. Control: Undifferentiated HL60 cells and DMSO: DMSO-induced differentiated HL60 cells.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 86 89 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Berger1">[1]</xref>
###xml 90 93 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi1">[3]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi2">[6]</xref>
###xml 363 366 363 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi2">[6]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee1">[8]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wissmann1">[12]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee2">[17]</xref>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 526 531 <span type="species:ncbi:9606">human</span>
The methylated histone H3-K4 and K9 mark gene activation and repression, respectively [1]-[3]. LSD1, the first identified histone demethylase [6], has been shown to either repress a cohort of target genes through demethylation of H3-K4(M2) or activate other targets via removing the repressive mark H3-K9(M2), dependent on its interaction with different partners [6]-[8], [12], [17]. In the present study, we provide evidence that LSD1 is required for transcriptional repression of the hTERT gene in both normal and cancerous human cell lines.
###end p 38
###begin p 39
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wang2">[29]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wang3">[30]</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Cong1">[22]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lin1">[26]</xref>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
Previous observations showed that the entire hTERT gene was embedded in a highly condensed chromatin in human normal fibroblasts with a tight repression of hTERT transcription [29], [30]. When treated with a HDAC inhibitor, the local chromatin became open due to the increased histone acetylation, which thus allowed the transcriptional activation of the hTERT gene [22]-[26]. These data indicate an important role for HDAC-mediated histone deacetylation in repressing hTERT expression in telomerase-deficient cells. It is evident from the present investigation that LSD1 is similarly required for the establishment of repressive hTERT chromatin in normal fibroblasts. The activation of an optimal hTERT transcription can be achieved only when LSD1 and HDACs are both inhibited. Taken together, LSD1-mediated H3-K4 demethylation and HDAC-mediated histone deacetylation cooperate to establish a repressive transcriptional environment at the hTERT promoter region in human normal fibroblasts. Moreover, the recruitment of LSD1 to the hTERT promoter observed in differentiated HL60 cells provides independent evidence for its participation in the stable repression of the hTERT gene. It is currently unclear whether other histone demethylases are involved in the H3-K4 demethylation at the hTERT chromatin. This issue is now being addressed in our laboratory.
###end p 39
###begin p 40
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Wang1">[13]</xref>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
Intriguingly, the temporal patterns of expression of specific components of the LSD1 complex during the mammalian development cause a switch of LSD1 function from repression to activation, or reverse [13]. Therefore, we compared the transcriptional effect of LSD1 on the hTERT gene between cancer and normal cells. All the tested cancer cells including HeLa, SiHa, SW756 and A549 expressed hTERT mRNA and telomerase activity, but the pharmacological inhibition of LSD1 activity or depletion of its expression was capable of further up-regulating hTERT mRNA and telomerase activity levels, which clearly indicates an identical inhibitory effect of LSD1 on hTERT transcription in both normal and cancer cells. More importantly, the ChIP result demonstrated the LSD1 occupancy on the hTERT proximal promoter. Consistent with its functional activity, inhibition of LSD1 led to increased histone H3-K4 (M2) at the hTERT promoter region. In contrast, there were no detectable changes in H3-K9 methylation locally. It seems that LSD1 only targets H3-K4 for its demethylation at the hTERT promoter. Moreover, the LSD1-mediated H3-K4 demethylation was confined to the core promoter region without a further extension to upstream nucleosomes based on our unpublished data.
###end p 40
###begin p 41
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Berger1">[1]</xref>
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi1">[3]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Liu2">[34]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Guccione1">[38]</xref>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Horikawa2">[36]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Takakura2">[37]</xref>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee3">[40]</xref>
###xml 958 961 958 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Lee1">[8]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Shi3">[16]</xref>
H3-K4 methylation alters the chromatin folding, leading to increased accessibility of DNA to proteins that mediate transcription [1]-[3]. It has been shown that the methylated H3-K4 is one of the prerequisites for the E-box binding by c-MYC on MYC target promoters [34], [38]. Given the fact that hTERT gene is a direct target of c-MYC [36], [37], the LSD1-mediated H3-K4 demethylation might prevent the c-MYC binding to the hTERT promoter, which in turn attenuates a transcriptional activity of the hTERT gene. Consistent with this hypothesis, we indeed observed that the depletion of LSD1 led to not only increased H3-K4(M2) but also H3-K4(M3) at the hTERT proximal promoter in HeLa cells (data not shown). In addition, recent studies have revealed an intimate cross-talk between LSD1 and deacetylating enzymes, and histone demethylation can be a secondary target of HDAC inhibitors [40]. LSD1 interacts with CoREST which is in the HDAC-containing complex [8], [16], and thus it may further repress gene transcription program via indirectly promoting histone deacetylation. Consistently, we observed concomitant increases in histone H3-K4(M2) and H3 acetylation in cervical cancer cells treated with either LSD1 inhibitor or its specific siRNA. Taken together, LSD1 is capable of regulating the chromatin structure of the hTERT promoter region at multiple levels.
###end p 41
###begin p 42
Although LSD1 was observed to occupy the hTERT proximal promoter region, as demonstrated in our ChIP assay, it remains unclear how it is recruited there. We examined a potential interaction of LSD1 with the transcription factors Sp1 and MYC family members, the key regulators for hTERT transcription, and none of them were associated with LSD1 under our immunoprecipitation settings. It is thus plausible that LSD1 physically associates with other co-factors that are in turn tethered to the hTERT proximal promoter.
###end p 42
###begin p 43
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
To conclude, the present study demonstrates that the histone demethylase LSD1 is required for the transcriptional repression of the hTERT gene in both normal and cancerous cells. By directly demethylating H3-K4 and indirectly promoting H3 acetylation associated with the hTERT core promoter, LSD1 participates in the establishment of a stable repression state of the hTERT gene in human normal or differentiated malignant cells. Our findings thus provide insights into the regulatory mechanism underlying telomerase silencing and activation in human cells, and have implications in cancer and stem cell biology.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Cell lines, culture conditions, and chemicals
###end title 45
###begin p 46
###xml 189 190 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 669 673 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Xu1">[39]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 275 279 <span type="species:ncbi:9913">calf</span>
Human cervical cancer cell lines HeLa, SiHa and SW756, lung carcinoma cell line A549, normal fetal lung fibroblasts MRC5, and leukemic cell line HL60 were cultured at 37degreesC/95%air/5%CO2 in RPMI 1640 medium (Life Technologies, Paisley, Scotland, UK) containing 10% fetal calf serum, 100 units/ml penicillin, and 2 mM L-glutamine. The specific LSD1 inhibitor tranylcypromine and histone deacetylase (HDAC) inhibitor trichostatin A (TSA) were purchased from Biomol International LP (Plymouth Meeting, PA, USA) and Sigma-Aldrich Sweden AB (Stockholm, Sweden), respectively. HL60 cells were treated with 1.25% DMSO for 48 hours to induce their terminal differentiation [39].
###end p 46
###begin title 47
siRNA treatment
###end title 47
###begin p 48
Chemical modified Stealthtrade mark siRNA targeting LSD1 and CoREST, and control siRNA were bought from Invitrogen (Carlsbad, CA, USA). The sequences for LSD1 and CoREST were UUU CCA UGA UAC CAG CAG CUU CUC C and AAG AUU GUC CCG UUC UUG ACU GCG U, respectively. MRC5 and cervical cancer cells were transfected with siRNA using Lipofectamine2000 (Invitrogen) according to the manufacturer's protocol.
###end p 48
###begin title 49
Total RNA extraction and RT-PCR
###end title 49
###begin p 50
###xml 157 162 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hTERT</italic>
###xml 197 201 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Xu3">[46]</xref>
###xml 525 529 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Xu3">[46]</xref>
###xml 565 597 550 582 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAC TTC TTG GCA GAG TTG TC-3&#8242;</named-content>
###xml 612 643 597 628 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTG AAA GAG TTG CAG ATC C-3&#8242;</named-content>
###xml 737 769 722 754 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGG ATG CTC TTC TGG CAT AA-3&#8242;</named-content>
###xml 784 817 769 802 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGA GGT TTC CTT TTT GCT CTA-3&#8242;</named-content>
Total cellular RNA was extracted using ULTRASPECtrade mark-II RNA kit (Biotecx Lab, Houston, TX, USA). cDNA synthesis, the RT-PCR primers and conditions for hTERT mRNA were as described previously [46]. beta2-M mRNA expression was used as a control for RNA loading and RT efficiency and was amplified with its specific primers for 26 cycles. PCR for both hTERT and beta2-M mRNA was optimised to keep amplification in a linear phase, which allowed a semi-quantitative evaluation for the level of hTERT transcript as described [46]. The PCR primers for LSD1 mRNA are 5'-GAC TTC TTG GCA GAG TTG TC-3' (forward) and 5'-GTG AAA GAG TTG CAG ATC C-3' (reverse). RT-PCR for CoREST mRNA was carried out using the following primer pair: (forward) 5'-GGG ATG CTC TTC TGG CAT AA-3' and (reverse) 5'-GGA GGT TTC CTT TTT GCT CTA-3'.
###end p 50
###begin title 51
Histone and total cellular protein extraction, and western blot
###end title 51
###begin p 52
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ge1">[33]</xref>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 557 568 <span type="species:ncbi:3704">horseradish</span>
Preparation of a total histone fraction from nuclei was done by extraction with a dilute acid as described [33]. Total cellular proteins were extracted with RAIP lysis buffer. Two microg of histone proteins or 20 microg of total cellular proteins were resolved by sodium dodecyl sulate-polyacrylamide gel electrophoresis and transferred to an intracellulos membrane. The membranes were probed with the specific antibodies against methylated histone H3-K4(M1, M2 and M3), H3-K9(M1, M2 and M3), acetylated H3 or LSD1 (Upstate, NY, USA) followed by anti-mouse horseradish peroxidase-conjugated IgG and developed with the enhanced chemiluminescent method (ECL, Amersham, UK).
###end p 52
###begin title 53
Telomerase activity assay
###end title 53
###begin p 54
TeloTAGGG Telomerase PCR ELISA (Roche Diagnostics Scandinavia AB, Stockholm, Sweden) based on Telomeric Repeats Amplification Protocol was used to determine telomerase activity in all samples in duplicate according to manufacturer's instruction (40). One microg of protein from total cell lysates was added into the reaction mixture and the generated telomere product was PCR-amplified using 23 cycles. Four microl of products was used for ELISA assay and the level of telomerase activity was arbitrarily expressed as absorbance (OD450-OD690).
###end p 54
###begin title 55
Luciferase activity assay
###end title 55
###begin p 56
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Takakura2">[37]</xref>
###xml 314 332 <span type="species:ncbi:6136">Renilla reniformis</span>
Transfection for luciferase activity assay was performed in 24-well plates using Lipofectamine2000 (Invitrogen). The hTERT luciferase reporter (p181), kindly provided by Dr. S Kyo (Kanazawa University, Japan), harbors the core promoter sequence of the hTERT 5'-flanking region [37]. p181 was co-transfected with a Renilla reniformis luciferase-containing plasmid, which is under control of the thymidine kinase (TK) promoter. The transfected cells were then treated with different concentrations of tranylcypromine. Luciferase activity in the cell lysates was determined by using a dual luciferase reporter assay system (Promega, WI, USA) 48 hrs post-transfection, and the hTERT promoter-driven firefly luciferase activity was normalized to the TK renilla activity.
###end p 56
###begin title 57
ChIP assay
###end title 57
###begin p 58
###xml 33 37 33 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ge1">[33]</xref>
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Liu2">[34]</xref>
###xml 829 833 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ge1">[33]</xref>
###xml 835 839 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Liu2">[34]</xref>
###xml 944 979 938 973 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCA GGC CGG GCT CCC AGT GGA T-3&#8242;</named-content>
###xml 994 1030 988 1024 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGC TTC CCA CGT GCG CAG CAG GA-3&#8242;</named-content>
###xml 1089 1093 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001446-Ge1">[33]</xref>
ChIP assay was done as described [33], [34]. The HeLa, SiHa and HL60 cells, under different treatment conditions, were cross-linked by incubating them in 1% (vol/vol) formaldehyde-containing medium for 10 mins at 37degreesC and then sonicated to make soluble chromatin with DNA fragments between 200 and 1000 bps. The antibodies against LSD1, H3-K4(M2), H3-K9(M2), and acetylated histone H3 (Upstate, NY, USA) were used to precipitate DNA fragments bound by their corresponding elements. The protein-DNA complex was collected with protein A or G Sepharose beads (Upstate), eluted, and reverse cross-linked. Following treatment with Protease K (Sigma), the samples were extracted with phenol-chloroform and precipitated with ethanol. The recovered DNA was re-suspended in TE buffer and used for the PCR amplification as described [33], [34]. The PCR primers for the proximal promoter regions (spanning between -296 and -22 relative to ATG) were 5'-CCA GGC CGG GCT CCC AGT GGA T-3' (forward) and 5'-GGC TTC CCA CGT GCG CAG CAG GA-3' (reverse). The primers for GAPDH were described elsewhere [33].
###end p 58
###begin p 59
We thank Dr. S Kyo (Kanazawa University, Japan) for kindly providing plasmids.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
The complex language of chromatin regulation during transcription.
###end article-title 61
###begin article-title 62
Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark.
###end article-title 62
###begin article-title 63
Dynamic regulation of histone lysine methylation by demethylases.
###end article-title 63
###begin article-title 64
The retinoblastoma binding protein RBP2 is an H3K4 demethylase.
###end article-title 64
###begin article-title 65
RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.
###end article-title 65
###begin article-title 66
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
###end article-title 66
###begin article-title 67
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
###end article-title 67
###begin article-title 68
An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation.
###end article-title 68
###begin article-title 69
Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.
###end article-title 69
###begin article-title 70
Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.
###end article-title 70
###begin article-title 71
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
###end article-title 71
###begin article-title 72
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
###end article-title 72
###begin article-title 73
Opposing LSD1 complexes function in developmental gene activation and repression programmes.
###end article-title 73
###begin article-title 74
###xml 0 8 <span type="species:ncbi:4896">S. pombe</span>
S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription.
###end article-title 74
###begin article-title 75
###xml 29 39 <span type="species:ncbi:7227">Drosophila</span>
Heterochromatin formation in Drosophila is initiated through active removal of H3K4 methylation by the LSD1 homolog SU(VAR)3-3.
###end article-title 75
###begin article-title 76
Regulation of LSD1 histone demethylase activity by its associated factors.
###end article-title 76
###begin article-title 77
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
###end article-title 77
###begin article-title 78
###xml 14 19 <span type="species:ncbi:9606">human</span>
Telomeres and human disease: ageing, cancer and beyond.
###end article-title 78
###begin article-title 79
###xml 35 40 <span type="species:ncbi:9606">human</span>
A survey of telomerase activity in human cancer.
###end article-title 79
###begin article-title 80
Conditional telomerase induction causes proliferation of hair follicle stem cells.
###end article-title 80
###begin article-title 81
Effects of telomerase and telomere length on epidermal stem cell behavior.
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human telomerase and its regulation.
###end article-title 82
###begin article-title 83
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
###end article-title 83
###begin article-title 84
Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
###end article-title 84
###begin article-title 85
Studies of the molecular mechanisms in the regulation of telomerase activity.
###end article-title 85
###begin article-title 86
Multiple tumor suppressor pathways negatively regulate telomerase.
###end article-title 86
###begin article-title 87
###xml 114 119 <span type="species:ncbi:9606">human</span>
The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
###end article-title 87
###begin article-title 88
###xml 87 92 <span type="species:ncbi:9606">human</span>
Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells.
###end article-title 88
###begin article-title 89
###xml 68 73 <span type="species:ncbi:9606">human</span>
Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter.
###end article-title 89
###begin article-title 90
The hTERT gene is embedded in a nuclease-resistant chromatin domain.
###end article-title 90
###begin article-title 91
Telomerase activation by histone deacetylase inhibitor in normal cells.
###end article-title 91
###begin article-title 92
###xml 34 39 <span type="species:ncbi:9606">human</span>
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.
###end article-title 92
###begin article-title 93
Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation.
###end article-title 93
###begin article-title 94
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
###end article-title 94
###begin article-title 95
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
###end article-title 95
###begin article-title 96
###xml 55 60 <span type="species:ncbi:9606">human</span>
Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
###end article-title 96
###begin article-title 97
###xml 11 16 <span type="species:ncbi:9606">human</span>
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
###end article-title 97
###begin article-title 98
###xml 36 41 <span type="species:ncbi:9606">human</span>
Myc-binding-site recognition in the human genome is determined by chromatin context.
###end article-title 98
###begin article-title 99
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.
###end article-title 99
###begin article-title 100
Functional interplay between histone demethylase and deacetylase enzymes.
###end article-title 100
###begin article-title 101
###xml 98 103 <span type="species:ncbi:9606">human</span>
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
###end article-title 101
###begin article-title 102
Differentiation of immortal cells inhibits telomerase activity.
###end article-title 102
###begin article-title 103
###xml 23 28 <span type="species:ncbi:9606">human</span>
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.
###end article-title 103
###begin article-title 104
Supression of telomerase activity in HL60 cells after treatment with differentiating agents.
###end article-title 104
###begin article-title 105
Regulation of telomerase activity in immortal cell lines.
###end article-title 105
###begin article-title 106
Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia.
###end article-title 106
###begin p 107
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 107
###begin p 108
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by grants from The Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, Swedish Society of Medicine, Stockholm County Council and the Karolinska Institute Foundation (D Xu). The funders played no part in the work related to this manuscript.
###end p 108

